Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque (original) (raw)

• Fouchier, R.A. et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423, 240 (2003).
  Article CAS Google Scholar
• Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263–270 (2003).
  Article CAS Google Scholar
• Ksiazek, T.G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953–1966 (2003).
  Article CAS Google Scholar
• Peiris, J.S. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325 (2003).
  Article CAS Google Scholar
• Guan, Y. et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276–278 (2003).
  Article CAS Google Scholar
• Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303, 1666–1669 (2004).
• Snijder, E.J. et al. Unique and conserved features of genome and proteome of SARS-conronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331, 991–1004 (2003).
  Article CAS Google Scholar
• Marra, M.A. et al. The genome sequence of the SARS-associated coronavirus. Science 300, 1399–1404 (2003).
  Article CAS Google Scholar
• Nicholls, J.M. et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361, 1773–1778 (2003).
  Article Google Scholar
• Peiris, J.S. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767–1772 (2003).
  Article CAS Google Scholar
• Bisht, H. et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectiveloy immunizes mice. Proc. Natl. Acad. Sci. USA 101, 6641–6646 (2004).
  Article CAS Google Scholar
• Bukreyev, A. et al. Mucosal immunization of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 363, 2122–2127 (2004).
  Article CAS Google Scholar
• Yang, Z. et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428, 561–564 (2004).
  Article CAS Google Scholar
• Hogan, R. et al. Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1. J. Virol. 78, 11416–11421 (2004).
  Article CAS Google Scholar
• Zhong, N.S. et al. Epidemiological and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 362, 1353–1358 (2004).
  Article Google Scholar
• Subbarao, K. et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78, 3572–3577 (2004).
  Article CAS Google Scholar
• Hensley, L. et al. Interferon-β 1a and SARS coronavirus replication. Emerg. Infect. Dis. 10, 317–319 (2004).
  Article CAS Google Scholar
• Sainz, B. Jr . et al. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 329, 11–17 (2004).
  Article CAS Google Scholar
• Haagmans, B.L. et al. Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10, 290–293 (2004).
  Article CAS Google Scholar
• Rowe, T. et al. Macaque model for severe acute respiratory syndrome. J. Virol. 78, 11401–11404 (2004).
  Article CAS Google Scholar
• Chen, Z. et al. Recombinant modified vaccinia virus ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J. Virol. 79, 2678–2688 (2005).
  Article CAS Google Scholar
• Qin, C. et al. An animal model of SARS produced by infection of macaca mulata with SARS coronavirus. J. Pathol. 206, 251–259 (2005).
  Article Google Scholar
• Joost Haasnoot, P.C.J., Cupac, D. & Berkhout, B. Inhibition of virus replication by RNA interference. J. Biomed. Sci. 10, 607–616 (2003).
  Article CAS Google Scholar
• Zheng, B. et al. Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus. Antivir. Ther. 9, 365–374 (2004).
  CAS PubMed Google Scholar
• Elmen, J. et al. SARS virus inhibited by siRNA. Preclinica. 2, 135–142 (2004).
  CAS Google Scholar
• Zhang, Y. et al. Silencing SARS-CoV protein expression in cultured cells by RNA interference. FEBS Lett. 560, 141–146 (2004).
  Article CAS Google Scholar
• Zhang, R. et al. Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA. Chin. Med. J. (Engl.) 116, 1262–1264 (2003).
  CAS Google Scholar
• Wang, Z. et al. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells. J. Virol. 78, 7523–7527 (2004).
  Article CAS Google Scholar
• Ghanayem, N.S. et al. Stability of dopamine and epinephrine solutions up to 84 hours. Pediatr. Crit. Care Med. 2, 315–317 (2001).
  Article CAS Google Scholar
• Thomas, N.J. et al. Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure. Pediatr. Crit. Care Med. 6, 160–165 (2005).
  Article Google Scholar
• Lu, P.Y., Enist, D. & Mina, M. Method of achieving persistent transgene expression. US patent application. 20030148975, PCT/EP00/13297 (2000).
• Massaro, D., Massaro, G.D. & Clerch, L.B. Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L1066–1070 (2004).
  Article CAS Google Scholar
• Bitko, V., Musiyenko, A., Shulyayeva, O. & Barik, S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11, 50–55 (2004).
  Article Google Scholar
• Tompkins, S.M., Lo, C.Y., Tumpey, T.M. & Epstein, S.L. Protection against lethal influenza virus challenge by RNA interference in vivo. Proc. Natl. Acad. Sci. USA 101, 8682–8686 (2004).
  Article CAS Google Scholar
• Ge, Q. et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA 101, 8676–8681 (2004).
  Article CAS Google Scholar
• Boeckle, S. et al. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J. Gene Med. 6, 1102–1111 (2004).
  Article CAS Google Scholar
• Delepine, P. et al. Biodistribution study of phosphonolipids: a class of non-viral vectors efficient in mice lung-directed gene transfer. J. Gene Med. 5, 600–608 (2003).
  Article CAS Google Scholar
• Bonnard, E., Mazarguil, H. & Zajac, J.M. Peptide nucleic acids targeted to the mouse proNPFF(A) reveal an endogenous opioid tonus. Peptides 23, 1107–1113 (2002).
  Article CAS Google Scholar
• Semizarov, D. et al. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl. Acad. Sci. USA 100, 6347–6352 (2003).
  Article CAS Google Scholar
• Chi, J.T. et al. Genomewide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 6364–6369 (2003).
  Article Google Scholar
• Jackson, A. et al. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21, 635–637 (2003).
  Article CAS Google Scholar
• Sledz, C.A. et al. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834–839 (2003).
  Article CAS Google Scholar
• Kariko, K., Bhuyan, P., Capodici, J. & Weissman, D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172, 6545–6549 (2004).
  Article CAS Google Scholar
• Judge, A.D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457–462 (2005).
  Article CAS Google Scholar
• Hornung, V. et al. Sequence-specific potent inductin of IFN-α by short interfering RNA in plasmacytoid dentritic cells through TLR7. Nat. Med. 11, 263–70 (2005).
  Article CAS Google Scholar
• Heidel, J.D. et al. Lack of interferon response in animals to naked siRNAs. Nat. Biotechnol. 22, 1579–1582 (2004).
  Article CAS Google Scholar
• Ware, L.B. & Matthay, M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334–1349 (2000).
  Article CAS Google Scholar
• Yuen, K.Y. et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351, 467–471 (1998).
  Article CAS Google Scholar
• Huang, K.J. et al. An interferon-gamma-related cytokine storm in SARS patients. J. Med. Virol. 75, 185–194 (2005).
  Article CAS Google Scholar
• Cinatl, J. et al. Treatment of SARS with human interferons. Lancet 362, 293–294 (2003).
  Article CAS Google Scholar